Sufentanil NanoTab PCA System (Zalviso)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sufentanil NanoTab PCA System (Zalviso), covering 2014-02-03 to 2014-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery [Phase 3]